Labdhi Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 23 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by CDSCO (India). Customs aggregates show $1.9M of exports covering 230 molecules to 8 destinations in 2025.
| Site | FDA FEI |
|---|---|
| ahmedabad 382 481, India | Not on file |
| himatnagar 383 001sabarkantha, India | Not on file |
| Gidc, India | Not on file |
| tal kalolchhatralgand hinagar, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DIGEMAPS (DO) | 23 | None |
| CDSCO (India) | None | 4 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $234K | 6 |
| 2025 | Not reported | $1.9M | 8 |
| 2024 | Not reported | $1.3M | 10 |
| 2023 | Not reported | $737K | 17 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Labdhi Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.